Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF592 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929372 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DYNC1I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
THOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYZL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRTN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP98 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928907 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on